Brown, Lisle/Cummings’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Brown, Lisle/Cummings's LLY Position: Q3 2026 in Review
Brown, Lisle/Cummings reduced its Eli Lilly (LLY) stake by 8.3% in Q3 2026, selling an estimated $324K and leaving 3,033 shares worth $3.51M. The position accounts for 0.77% of the portfolio, ranked #28.
Brown, Lisle/Cummings first reported a position in LLY in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.97M in Q2 2026. 3,679 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Brown, Lisle/Cummings held 3,033 shares of Eli Lilly worth $3.51M as of Q3 2026.
- Brown, Lisle/Cummings sold 275 Eli Lilly shares in Q3 2026, an estimated $324K.
- Eli Lilly made up 0.77% of Brown, Lisle/Cummings's portfolio in Q3 2026, its #28 holding.
- Brown, Lisle/Cummings first reported a position in Eli Lilly in Q4 2021 and has held it in 20 quarters since.
- Brown, Lisle/Cummings's Eli Lilly position peaked at $3.97M in Q2 2026.
- 3,679 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q3 2026, filed 16 Oct 2026.